Skip to main content
Top
Published in: BMC Nephrology 1/2002

Open Access 01-12-2002 | Research article

Hospitalized poisonings after renal transplantation in the United States

Authors: Kevin C Abbott, Rebecca A Viola, Lawrence Y Agodoa

Published in: BMC Nephrology | Issue 1/2002

Login to get access

Abstract

Background

The national incidence of and risk factors for hospitalized poisonings in renal transplant recipients has not been reported.

Methods

Historical cohort study of 39,628 renal transplant recipients in the United States Renal Data System between 1 July 1994 and 30 June 1998. Associations with time to hospitalizations for a primary diagnosis of poisonings (ICD-9 codes 960.x-989.x) within three years after renal transplant were assessed by Cox Regression.

Results

The incidence of hospitalized poisonings was 2.3 patients per 1000 person years. The most frequent causes of poisonings were immunosuppressive agents (25.3%), analgesics/antipyretics (14.1%), psychotropic agents (10.0%), and insulin/antidiabetic agents (7.1%). In Cox Regression analysis, low body mass index (BMI, <21.6 vs. >28.3 kg/m2, adjusted hazard ratio (AHR), 3.02, 95% CI, 1.45–6.28, and allograft rejection, AHR 1.83, 95% CI, 1.15–2.89, were the only factors independently associated with hospitalized poisonings. Hospitalized poisonings were independently associated with increased mortality (AHR, 1.54, 95% CI 1.22–1.92, p = 0.002).

Conclusions

Hospitalized poisonings were associated with increased mortality after renal transplantation. However, almost all reported poisonings in renal transplant recipients were due to the use of prescribed medications. Allograft rejection and low BMI were the only independent risk factors for poisonings identified in this population.
Appendix
Available only for authorised users
Literature
2.
go back to reference Chang SH, Lim CS, Low TS, Chong HT, Tan SY: Cyclosporine-associated encephalopathy: a case report and literature review. Transplant Proc. 2001, 33: 3700-1. 10.1016/S0041-1345(01)02510-6.CrossRefPubMed Chang SH, Lim CS, Low TS, Chong HT, Tan SY: Cyclosporine-associated encephalopathy: a case report and literature review. Transplant Proc. 2001, 33: 3700-1. 10.1016/S0041-1345(01)02510-6.CrossRefPubMed
4.
go back to reference Chari RS, Hemming AW, Cattral M: Successful kidney pancreas transplantation from donor with methanol intoxication. Transplantation. 1998, 66: 674-5. 10.1097/00007890-199809150-00025.CrossRefPubMed Chari RS, Hemming AW, Cattral M: Successful kidney pancreas transplantation from donor with methanol intoxication. Transplantation. 1998, 66: 674-5. 10.1097/00007890-199809150-00025.CrossRefPubMed
5.
go back to reference Ravishankar DK, Kashi SH, Lam FT: Organ transplantation from donor who died of cyanide poisoning: a case report. Clin Transplant. 1998, 12: 142-3.PubMed Ravishankar DK, Kashi SH, Lam FT: Organ transplantation from donor who died of cyanide poisoning: a case report. Clin Transplant. 1998, 12: 142-3.PubMed
6.
go back to reference Abbott KC, Duran M, Hypolite I, et al: Hospitalizations for bacterial endocarditis after renal transplantation in the United States. J Nephrol. 2001, 14: 353-60.PubMed Abbott KC, Duran M, Hypolite I, et al: Hospitalizations for bacterial endocarditis after renal transplantation in the United States. J Nephrol. 2001, 14: 353-60.PubMed
7.
go back to reference Tveit DP, Hypolite I, Bucci J, et al: Risk factors for hospitalizations resulting from pulmonary embolism after renal transplantation in the United States. J Nephrol. 2001, 14: 361-8.PubMed Tveit DP, Hypolite I, Bucci J, et al: Risk factors for hospitalizations resulting from pulmonary embolism after renal transplantation in the United States. J Nephrol. 2001, 14: 361-8.PubMed
8.
go back to reference Abbott KC, Hypolite IO, Hshieh P, et al: Hospitalized congestive heart failure after renal transplantation in the United States. Ann Epidemiol. 2002, 12: 115-22. 10.1016/S1047-2797(01)00272-1.CrossRefPubMed Abbott KC, Hypolite IO, Hshieh P, et al: Hospitalized congestive heart failure after renal transplantation in the United States. Ann Epidemiol. 2002, 12: 115-22. 10.1016/S1047-2797(01)00272-1.CrossRefPubMed
9.
go back to reference Abbott KC, Bucci JR, Cruess D, Taylor AJ, Agodoa LY: Graft loss and acute coronary syndromes after renal transplantation in the United States. J Am Soc Nephrol. 2002, 13: 2560-9.CrossRefPubMed Abbott KC, Bucci JR, Cruess D, Taylor AJ, Agodoa LY: Graft loss and acute coronary syndromes after renal transplantation in the United States. J Am Soc Nephrol. 2002, 13: 2560-9.CrossRefPubMed
10.
go back to reference Hypolite IO, Bucci J, Hshieh P, Cruess D, Agodoa LY, Yuan CM, Taylor AJ, Abbott KC: Acute coronary syndromes after renal transplantation in patients with end-stage renal disease resulting from diabetes. Am J Transplant. 2002, 2: 274-81. 10.1034/j.1600-6143.2002.20313.x.CrossRefPubMed Hypolite IO, Bucci J, Hshieh P, Cruess D, Agodoa LY, Yuan CM, Taylor AJ, Abbott KC: Acute coronary syndromes after renal transplantation in patients with end-stage renal disease resulting from diabetes. Am J Transplant. 2002, 2: 274-81. 10.1034/j.1600-6143.2002.20313.x.CrossRefPubMed
11.
go back to reference David Kleinbaum: Survival Analysis :. A Self-Learning Text (Statistics in the Health Sciences). Springer Verlag; New York, New York, May 1996 David Kleinbaum: Survival Analysis :. A Self-Learning Text (Statistics in the Health Sciences). Springer Verlag; New York, New York, May 1996
12.
go back to reference Kruger HU, Bross-Bach U, Proksch B, Schmidt H, Dopfer R, Ehninger G: A case of accidental cyclosporin overdose with pharmacokinetic analysis. Bone Marrow Transplant. 1988, 3: 167-9.PubMed Kruger HU, Bross-Bach U, Proksch B, Schmidt H, Dopfer R, Ehninger G: A case of accidental cyclosporin overdose with pharmacokinetic analysis. Bone Marrow Transplant. 1988, 3: 167-9.PubMed
13.
go back to reference Yeh CN, Hsieh CH, Hung CM, Jeng LB, Chao TC, Chen MF: Acute overdoses of tacrolimus (FK 506). Dig Dis Sci. 1999, 44: 1650-2. 10.1023/A:1026635615532.CrossRefPubMed Yeh CN, Hsieh CH, Hung CM, Jeng LB, Chao TC, Chen MF: Acute overdoses of tacrolimus (FK 506). Dig Dis Sci. 1999, 44: 1650-2. 10.1023/A:1026635615532.CrossRefPubMed
14.
go back to reference Dines CM: Improving renal transplant pain management. Hosp Case Manag. 1999, 7: 105-7.PubMed Dines CM: Improving renal transplant pain management. Hosp Case Manag. 1999, 7: 105-7.PubMed
15.
go back to reference Abbott K, Hypolite I, Viola R, Poropatich R, Hshieh P, Cruess D, Hawkes C, Agodoa L: Hospitalizations for cytomegalovirus disease after renal transplantation in the United States. Ann Epidemiol. 2002, 12: 402-10.1016/S1047-2797(01)00283-6.CrossRefPubMed Abbott K, Hypolite I, Viola R, Poropatich R, Hshieh P, Cruess D, Hawkes C, Agodoa L: Hospitalizations for cytomegalovirus disease after renal transplantation in the United States. Ann Epidemiol. 2002, 12: 402-10.1016/S1047-2797(01)00283-6.CrossRefPubMed
16.
go back to reference Bechstein WO: Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int. 2000, 13: 313-26. 10.1007/s001470050708.CrossRefPubMed Bechstein WO: Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int. 2000, 13: 313-26. 10.1007/s001470050708.CrossRefPubMed
17.
go back to reference Vella JP, Sayegh MH: Interactions between cyclosporine and newer antidepressant medications. Am J Kidney Dis. 1998, 31: 320-3.CrossRefPubMed Vella JP, Sayegh MH: Interactions between cyclosporine and newer antidepressant medications. Am J Kidney Dis. 1998, 31: 320-3.CrossRefPubMed
18.
go back to reference Matzke GR, St Peter WL, Comstock TJ, Foote EF: Nephrology pharmaceutical care preceptorship: a programmatic and clinical outcomes assessment. Ann Pharmacother. 2000, 34: 593-9. 10.1345/aph.19245.CrossRefPubMed Matzke GR, St Peter WL, Comstock TJ, Foote EF: Nephrology pharmaceutical care preceptorship: a programmatic and clinical outcomes assessment. Ann Pharmacother. 2000, 34: 593-9. 10.1345/aph.19245.CrossRefPubMed
19.
go back to reference Kliger AS, Diamond LH: Patient safety in end-stage renal disease: How do we create a safe environment?. Adv Ren Replace Ther. 2001, 8: 131-7. 10.1053/jarr.2001.23991.CrossRefPubMed Kliger AS, Diamond LH: Patient safety in end-stage renal disease: How do we create a safe environment?. Adv Ren Replace Ther. 2001, 8: 131-7. 10.1053/jarr.2001.23991.CrossRefPubMed
20.
go back to reference Wong KM, Shek CC, Chau KF, Li CS: Abbreviated Tacrolimus Area-Under-the-Curve Monitoring for Renal Transplant Recipients. Am J Kidney Dis. 2000, 35 (4): 660-666.CrossRefPubMed Wong KM, Shek CC, Chau KF, Li CS: Abbreviated Tacrolimus Area-Under-the-Curve Monitoring for Renal Transplant Recipients. Am J Kidney Dis. 2000, 35 (4): 660-666.CrossRefPubMed
22.
go back to reference Chisholm MA, Mulloy LL, Jagadeesan M, DiPiro JT: Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clin Transplant. 2001, 15: 330-6. 10.1034/j.1399-0012.2001.150505.x.CrossRefPubMed Chisholm MA, Mulloy LL, Jagadeesan M, DiPiro JT: Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clin Transplant. 2001, 15: 330-6. 10.1034/j.1399-0012.2001.150505.x.CrossRefPubMed
23.
go back to reference Estimating workforce and training requirements for nephrologists through the year 2010. Ad Hoc Committee on Nephrology Manpower Needs. J Am Soc Nephrol. 1997, 8: S9-13. i–xxii, 1–32 passim Estimating workforce and training requirements for nephrologists through the year 2010. Ad Hoc Committee on Nephrology Manpower Needs. J Am Soc Nephrol. 1997, 8: S9-13. i–xxii, 1–32 passim
24.
go back to reference Bond MA: Health promotion and disease prevention in kidney transplant recipients. J Transpl Coord. 1998, 8: 221-4.CrossRefPubMed Bond MA: Health promotion and disease prevention in kidney transplant recipients. J Transpl Coord. 1998, 8: 221-4.CrossRefPubMed
Metadata
Title
Hospitalized poisonings after renal transplantation in the United States
Authors
Kevin C Abbott
Rebecca A Viola
Lawrence Y Agodoa
Publication date
01-12-2002
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2002
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-3-10

Other articles of this Issue 1/2002

BMC Nephrology 1/2002 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.